Black Rock Inc. Kala Pharmaceuticals, Inc. Transaction History

Black Rock Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.25 - $0.36 $1,556 - $2,241	-6,225 Reduced 0.78%	787,252 $175,000
Q2 2022 Aug 12, 2022	SELL	$0.3 - $1.31 $700,251 - $3.06 Million	-2,334,173 Reduced 74.63%	793,477 $238,000
Q1 2022 May 12, 2022	SELL	$0.61 - $1.84 $4,345 - $13,106	-7,123 Reduced 0.23%	3,127,650 $4.32 Million
Q4 2021 Feb 10, 2022	SELL	$1.16 - $2.74 $614,888 - $1.45 Million	-530,076 Reduced 14.46%	3,134,773 $3.8 Million
Q3 2021 Nov 09, 2021	SELL	$2.62 - $5.43 $142,955 - $296,277	-54,563 Reduced 1.47%	3,664,849 $9.6 Million

Q2 2021 Aug 11, 2021	BUY	$5.06 - $8.15 $18.8 Million - $30.3 Million	3,719,412 New	3,719,412 $19.7 Million

Ticker KALA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,464,160
Market Cap $10.4M
Description
Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. The company's product candidates include KPI-012, which is in clinical development stage for the treatment of persistent...

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

Stay updated on Black Rock Inc. with notifications on news.